ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,659.60
      -2.28%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.11
      0.00%
      Bitcoin
      57,068.95
      -0.49%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Krystal Biotech Inc (KRYS)

      7. Krystal Biotech Inc (KRYS) News

      KRYS

      Krystal Biotech (KRYS)

      Krystal Biotech Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KRYS
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      12/19/20237:00AMGlobeNewswire Inc.Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt (B-VEC)NASDAQ:KRYSKrystal Biotech Inc
      11/27/20237:00AMGlobeNewswire Inc.Krystal Biotech Announces EMA Validation of Marketing Authorization Application for VYJUVEK for the Treatment of Dystrophic Epidermolysis BullosaNASDAQ:KRYSKrystal Biotech Inc
      11/09/20237:00AMGlobeNewswire Inc.Krystal Biotech to Present at the Stifel 2023 Healthcare ConferenceNASDAQ:KRYSKrystal Biotech Inc
      11/06/20237:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
      11/06/20237:08AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRYSKrystal Biotech Inc
      11/06/20237:00AMGlobeNewswire Inc.Krystal Biotech Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:KRYSKrystal Biotech Inc
      10/30/20237:00AMGlobeNewswire Inc.Krystal Biotech to Report Third Quarter 2023 Financial Results on November 6, 2023NASDAQ:KRYSKrystal Biotech Inc
      10/02/202312:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
      09/28/20237:00AMGlobeNewswire Inc.Krystal Biotech to Present at the Chardan 7th Annual Genetic Medicines ConferenceNASDAQ:KRYSKrystal Biotech Inc
      09/07/20237:00AMGlobeNewswire Inc.Krystal Biotech to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:KRYSKrystal Biotech Inc
      09/05/20237:00AMGlobeNewswire Inc.Krystal Biotech Announces Orphan Drug Designation Granted to KB408 for the Treatment of Alpha-1 Antitrypsin DeficiencyNASDAQ:KRYSKrystal Biotech Inc
      08/21/20235:30PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
      08/16/20234:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
      08/15/20234:56PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
      08/11/20234:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
      08/10/20236:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
      08/07/20238:18AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
      08/07/20237:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
      08/07/20237:07AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRYSKrystal Biotech Inc
      08/07/20237:00AMGlobeNewswire Inc.Krystal Biotech Announces Second Quarter 2023 Financial Results and Operational HighlightsNASDAQ:KRYSKrystal Biotech Inc
      07/26/20234:14PMGlobeNewswire Inc.Krystal Biotech Announces Pipeline Expansion into Oncology and FDA Acceptance of IND Application for Lead Oncology Candidate KB707NASDAQ:KRYSKrystal Biotech Inc
      07/26/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
      07/18/20234:05PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:KRYSKrystal Biotech Inc
      07/10/20234:01PMGlobeNewswire Inc.Arbutus Appoints Two New ExecutivesNASDAQ:KRYSKrystal Biotech Inc
      07/03/20234:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
      07/03/20234:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
      07/03/20234:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
      07/03/20237:00AMGlobeNewswire Inc.Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of KB407 for the Treatment of Cystic FibrosisNASDAQ:KRYSKrystal Biotech Inc
      06/09/20237:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KRYSKrystal Biotech Inc
       Showing the most relevant articles for your search:NASDAQ:KRYS

      Your Recent History

      USOTC
      PAZRF
      Plaza Retail Reit (PK)
      BIT
      UC27EQ
      Unicredit Bank
      Delayed Upgrade Clock